학술논문
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
Document Type
Article
Author
Bosaeed, M.; Alanazi, H.; Jawhary, A.; Alanazi, R.; Almoaikel, K.; Aljeraisy, M.; Alothman, A.; Aljami, H.A.; Alahmadi, M.; Alenazi, M.W.; Almasoud, A.; Khalaf Alharbi, N.; Almaziad, S.; Alhatmi, H.; Balkhy, H.H.; Bittaye, M.; Aboagye, J.; Batawi, S.; Folegatti, P.; Ramos Lopez, F.; Ewer, K.; Gilbert, S.C.; Albaalharith, N.
Source
In: The Lancet Microbe . (The Lancet Microbe, January 2022, 3(1):e11-e20)
Subject
Language
English
ISSN
26665247